Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours Β· Estimated delivery Aug 14 - Aug 19
These positive changes can be just as meaningful as the weight loss itself
Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes/weight-loss med tirzepatide is over
The Journal of Frailty & Aging, 8 (3), 154
In a nutshell, the administration has signed agreements with pharmaceutical manufacturers Eli Lilly and Novo Nordisk that establish reduced pricing for a range of GLP-1 medications when purchased by Medicare and Medicaid and via TrumpRx, the Direct-To-Consumer prescription drug program set to go live early in 2026
For common thyroid conditions like hypothyroidism or Hashimoto's, GLP-1 medications are not contraindicated
The other arrived more recently as a weekly injection promising weight loss, blood sugar control, and heart health
